Price$30.98-0.95 (-2.98%)
01:30 PM07:45 PM
News · 26 weeks610%
2026-04-192026-10-11
Mix3190d
- Insider20(65%)
- SEC Filings3(10%)
- Other3(10%)
- Market3(10%)
- Analyst1(3%)
- Earnings1(3%)
Latest news
25 items- INSIDERSEC Form 4 filed by Doximity Inc.4 - Doximity, Inc. (0001516513) (Issuer)
- NEWSDOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class Action - Contact the FirmNEW YORK CITY, NY / ACCESS Newswire / October 16, 2026 / Levi & Korsinsky, LLP reminds purchasers of Doximity, Inc. (NYSE:DOCS) securities that a securities class action is pending on behalf of shareholders who acquired stock between August 8, 2024 and May 13, 2026. See if you could be eligible to recover. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.Three dates carry the loss. DOCS declined $8.29 per share (13%) on November 7, 2025; $5.59 per share (17%) on February 6, 2026; and $5.38 per share (23%) on May 14, 2026. That is roughly $19.26 per share of combined decline across the three events. Investors have until November 16, 2026 to seek lead plai
- PRDoximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2026 after market close on November 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inc
- PRDoximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and DoctorsDoximity helps to power U.S. News' Doctor Finder, Patient Connect appointment booking tools used by over 65 million Americans annually to find and schedule careDoximity (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it has extended its 13-year partnership with U.S. News & World Report, the nation's most trusted source of independent healthcare information, rankings and guidance to help patients identify the best care for their needs.The extension reinforces Doximity's position as a trusted data provider for U.S. News' physician- and hospital-facing products. For more than three decades, U.S. News has helped patients and families make some of their m
- NEWSLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. Lawsuit - DOCSNEW YORK CITY, NY / ACCESS Newswire / October 9, 2026 / Levi & Korsinsky, LLP notifies investors in Doximity, Inc. (NYSE:DOCS) that a securities class action has been filed on behalf of shareholders who purchased common stock between August 8, 2024 and May 13, 2026. Find out if you might qualify for recovery. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.DOCS holders absorbed three separate declines totaling $19.26 per share: $8.29 (13%) on November 7, 2025, $5.59 (17%) on February 6, 2026, and $5.38 (23%) on May 14, 2026, the last carrying the stock from $23.39 to $18.01. Motions for lead plaintiff appointment must be filed by November 16, 2026.What
- INSIDERSEC Form 4 filed by Doximity Inc.4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Yang Watkin Phoebe L. sold $34,456 worth of shares (1,290 units at $26.71) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 24,744 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- NEWSLevi & Korsinsky Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - DOCSNEW YORK CITY, NY / ACCESS Newswire / October 2, 2026 / Levi & Korsinsky, LLP highlights the contrast between Doximity, Inc.'s (NYSE:DOCS) public promises and its reported results for investors who purchased or acquired securities between August 8, 2024 and May 13, 2026. Check if you might be eligible to recover your investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.DOCS declined $8.29 per share (13%) on November 7, 2025, $5.59 per share (17%) on February 6, 2026, and a further $5.38 per share (23%) on May 14, 2026. LEAD PLAINTIFF DEADLINE: November 16, 2026.The PromiseQuarter after quarter, the Company projected strength: record engage
- INSIDERPresident Zatz Steven L was granted 152,427 shares, increasing direct ownership by 294% to 204,291 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- PRDoximity Named Leading Clinical AI Benchmark in Fireworks’ Cross-Industry IndexJoins Sierra and Harvey as category leaders spanning healthcare, customer support, and law Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has been named a founding partner in the launch of a new Specialized Intelligence Index of leading AI benchmarks compiled by Fireworks, the AI training and inference platform. As part of the launch, Doximity is publishing a new open-source benchmark for measuring clinical-grade AI. Called Bedside Bench, the benchmark has been built to test AI's ability to be a trusted partner to doctors where it matters most: at the bedside. Bedside Bench is one of several domain-specific evaluations
- INSIDERChief Accounting Officer Sitaram Siddharth converted options into 5,000 shares and sold $54,044 worth of shares (2,077 units at $26.02) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 96,045 units (SEC Form 4) (for withholding tax)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Wampler Kira Scherer converted options into 2,000 shares and sold $52,660 worth of shares (2,000 units at $26.33) as part of a pre-agreed trading plan (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- SECDoximity Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Doximity, Inc. (0001516513) (Filer)
- INSIDERDirector Spain Kevin was granted 8,084 shares, increasing direct ownership by 251% to 11,305 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Yang Watkin Phoebe L. was granted 8,084 shares, increasing direct ownership by 45% to 26,034 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Wampler Kira Scherer was granted 8,084 shares, increasing direct ownership by 41% to 27,923 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Cabral Timothy S was granted 8,084 shares, increasing direct ownership by 251% to 11,305 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Benjamin Regina M. was granted 8,084 shares, increasing direct ownership by 16% to 58,987 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Wampler Kira Scherer converted options into 2,000 shares and sold $49,900 worth of shares (2,000 units at $24.95) as part of a pre-agreed trading plan (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- PROverworked Doctors Bet on AI to Boost Their PayAs burnout drives more physicians toward early retirement, many see AI fluency as their best shot at higher earnings Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't. The findings are part of Doximity’s annual Physician Compensation Report, which also shows that the physician shortage continues to weigh he
- INSIDERChief Accounting Officer Sitaram Siddharth converted options into 5,000 shares, sold $44,144 worth of shares (1,770 units at $24.94) as part of a pre-agreed trading plan and covered exercise/tax liability with 3,882 shares, decreasing direct ownership by 0.70% to 93,122 units (SEC Form 4) (withholding tax)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERChief Financial Officer Sonefeldt Matthew covered exercise/tax liability with 15,311 shares, decreasing direct ownership by 3% to 486,238 units (SEC Form 4) to satisfy withholding tax4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERPresident Zatz Steven L covered exercise/tax liability with 4,482 shares, decreasing direct ownership by 8% to 51,864 units (SEC Form 4) to satisfy withholding tax4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERChief Executive Officer Tangney Jeffrey covered exercise/tax liability with 8,505 shares, decreasing direct ownership by 0.33% to 2,531,955 units (SEC Form 4) (withholding obligation)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Cabral Timothy S converted options into 7,500 shares and sold $293,325 worth of shares (7,500 units at $39.11) as part of a pre-agreed trading plan (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
DOCS FAQ
6 questionsWhere does DOCS stock trade?
Doximity Inc. (DOCS) is listed on NYSE.What sector and industry is DOCS in?
Doximity Inc. operates in the Technology sector, EDP Services industry.When did Doximity Inc. go public?
Doximity Inc. (DOCS) completed its IPO in 2021.What are analysts saying about DOCS?
Doximity Inc. has had 8 recent analyst actions on file. The most recent action was from Wells Fargo: Underweight with a $1800.00 price target on 2026-08-10. Recent price targets range from $1800.00 to $2000.00.What companies are similar to DOCS?
Notable peers in the same industry include NEE (NextEra Energy Inc.), PDD (PDD Holdings Inc.), INFY (Infosys Limited), WDAY (Workday Inc.), ZS (Zscaler Inc.). Compare DOCS side-by-side with any of them on Quantisnow.How can I track DOCS on Quantisnow?
Quantisnow aggregates Doximity Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DOCS to receive live email and push alerts on every new disclosure.